ADVISORY, Feb. 14, 2013 (GLOBE NEWSWIRE) --
What:
Isis Pharmaceuticals, Inc. [ISIS], the leading company in antisense drug discovery and development, will visit the NASDAQ MarketSite in Times Square.
In honor of the occasion, Lynne Parshall, Chief Operating Officer, will ring the Closing Bell.
